FINWIRES · TerminalLIVE
FINWIRES

March US Leading Index Falls More Than Expected After February Gain

作者

-- The Conference Board's measure of leading indicators fell by 0.6% in March, below expectations for a 0.2% decrease in a survey compiled by Bloomberg and following a 0.3% increase in February.

There were negative contributions from five of the 10 components, particularly building permits, business conditions expectations and stock prices. There were smaller positive contributions from the other five components, particularly nondefense capital goods new orders.

"After rising in February, the US LEI pulled back sharply in March, as building permits declined and consumer expectations and stock prices weakened," said Justyna Zabinska-La Monica, Senior Manager of Business Cycle Indicators at The Conference Board. "The LEI continues to signal a slowdown in the economy over the coming months, as higher oil prices and supply chain tensions will likely place additional upward pressure on inflation and further reduce consumers' purchasing power."

相關文章

Australia

Leerink Partners 將 Labcorp 的目標價從 347 美元下調至 340 美元。

根據FactSet調查的分析師報告,Labcorp (LH) 的平均評級為“增持”,平均目標價為311.35美元。 (報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們:https://www..com/contact-us)Price: $257.19, Change: $+0.05, Percent Change: +0.02%

$LH
Australia

午盤漲幅最大的股票

臨床階段製藥公司Avalyn Pharma (AVLN)週三晚間宣布,已將其規模擴大的首次公開募股(IPO)定價為每股18美元,發行約1,670萬股,目標募集資金約3億美元。 該股在納斯達克上市首日便大幅上漲,午後交易時段漲幅超過50%,達到約27.44美元,盤中成交量超過365萬股。 Everspin Technologies (MRAM)週四宣布與美國主要承包商達成協議,將為美國國防工業基地客戶提供Toggle MRAM製程技術和工程服務。該協議價值4000萬美元,有效期為兩年半。 該股盤中成交量從日均約53.3萬股飆升至超過1,260萬股,漲幅高達37%。 Viavi Solutions (VIAV) 股價上漲 15%,此前該公司公佈的第三財季業績和第四財季業績指引均超出市場預期。 當日成交量超過 1,510 萬股,而每日平均成交量約 587 萬股。Price: $27.00, Change: $+9.00, Percent Change: +50.00%

$AVLN$MRAM$VIAV
Australia

Argus將納斯達克目標股價從98美元上調至103美元。

根據FactSet調查的分析師數據,納斯達克(NDAQ)的平均評級為“買入”,平均目標價為110.06美元。 (報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們:https://www..com/contact-us)Price: $91.63, Change: $+0.36, Percent Change: +0.40%

$NDAQ